FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048991672> ?p ?o ?g. }

• W3048991672 endingPage "834" @default.
• W3048991672 startingPage "824" @default.
• W3048991672 abstract "Abstract Tuberculosis is an infectious disease with a major global impact, ranked in the top 10 mortality causes worldwide. In an immunocompetent individual, the host defence mechanisms control Mycobacterium tuberculosis infection and induce the latent form of the disease. However, in the presence of diseases or therapies, which exert an immunosuppressive effect, latent tuberculosis can be re‐activated. Psoriasis is an immune‐mediated, inflammatory disease, and its treatment has rapidly evolved over the last few years. It has long been recognized that the tumour necrosis factor (TNF)‐α inhibitors are associated with increased risk of reactivation of latent tuberculosis infection. Thus, international guidelines have been suggesting tuberculosis screening before starting the treatment with all biological agents since then. In addition, the institution of chemoprophylaxis in the presence of latent tuberculosis and the annual screening for tuberculosis thereafter have also been indicated. However, anti‐tuberculosis treatments can have significant side‐effects and there are currently several contraindications to their use. The risk benefit of starting anti‐tuberculous treatment should be carefully weighed up. The emergence of new biological drugs for the treatment of psoriasis, such as interleukin (IL)‐17 and IL‐23 inhibitors, has reignited the subject of tuberculosis reactivation as it is possible that IL‐17 and 23 blockade do not carry the same risk of TB reactivation as TNF‐α inhibitors. Although preclinical studies have shown that cytokines IL‐17 and IL‐23 have a possible role against infection with M. tuberculosis , data from clinical trials and post‐marketing surveillance with drugs that inhibit these cytokines appear to suggest that they are not crucial to this response. In this article, we review the available data on tuberculosis reactivation after the treatment of psoriasis with IL‐17 and IL‐23 inhibitors, and its possible impact on the way we currently manage latent tuberculosis infection before or after starting treatment with these new drugs." @default.
• W3048991672 created "2020-08-21" @default.
• W3048991672 creator A5034548796 @default.
• W3048991672 creator A5077025645 @default.
• W3048991672 creator A5082315246 @default.
• W3048991672 date "2020-09-01" @default.
• W3048991672 modified "2023-10-17" @default.
• W3048991672 title "Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change" @default.
• W3048991672 cites W1585461212 @default.
• W3048991672 cites W1607828984 @default.
• W3048991672 cites W1765079284 @default.
• W3048991672 cites W1878399872 @default.
• W3048991672 cites W1912289137 @default.
• W3048991672 cites W1971708477 @default.
• W3048991672 cites W1971786681 @default.
• W3048991672 cites W1984467626 @default.
• W3048991672 cites W1989324269 @default.
• W3048991672 cites W2001989551 @default.
• W3048991672 cites W2007946569 @default.
• W3048991672 cites W2020976497 @default.
• W3048991672 cites W2032537032 @default.
• W3048991672 cites W2038697517 @default.
• W3048991672 cites W2069064769 @default.
• W3048991672 cites W2070265035 @default.
• W3048991672 cites W2071109139 @default.
• W3048991672 cites W2114004413 @default.
• W3048991672 cites W2116553220 @default.
• W3048991672 cites W2117207917 @default.
• W3048991672 cites W2125595528 @default.
• W3048991672 cites W2132689682 @default.
• W3048991672 cites W2154138223 @default.
• W3048991672 cites W2154401560 @default.
• W3048991672 cites W2171382646 @default.
• W3048991672 cites W2359919307 @default.
• W3048991672 cites W2496133752 @default.
• W3048991672 cites W2499510596 @default.
• W3048991672 cites W2537379881 @default.
• W3048991672 cites W2555774932 @default.
• W3048991672 cites W2593291425 @default.
• W3048991672 cites W2596346717 @default.
• W3048991672 cites W2602321146 @default.
• W3048991672 cites W2615787984 @default.
• W3048991672 cites W2620033115 @default.
• W3048991672 cites W2620710772 @default.
• W3048991672 cites W2748863627 @default.
• W3048991672 cites W2768517818 @default.
• W3048991672 cites W2769106867 @default.
• W3048991672 cites W2801085776 @default.
• W3048991672 cites W2803613363 @default.
• W3048991672 cites W2831987875 @default.
• W3048991672 cites W2888626624 @default.
• W3048991672 cites W2890837529 @default.
• W3048991672 cites W2906844415 @default.
• W3048991672 cites W2907270898 @default.
• W3048991672 cites W2923076340 @default.
• W3048991672 cites W2924895007 @default.
• W3048991672 cites W2942180814 @default.
• W3048991672 cites W2944224722 @default.
• W3048991672 cites W2947452967 @default.
• W3048991672 cites W2967449819 @default.
• W3048991672 cites W2976654051 @default.
• W3048991672 cites W2985568363 @default.
• W3048991672 cites W2991496398 @default.
• W3048991672 cites W2998480788 @default.
• W3048991672 cites W3005206072 @default.
• W3048991672 cites W3006339989 @default.
• W3048991672 cites W3006575316 @default.
• W3048991672 cites W3008235635 @default.
• W3048991672 cites W3010998348 @default.
• W3048991672 cites W3012894524 @default.
• W3048991672 cites W3015065138 @default.
• W3048991672 cites W3015886911 @default.
• W3048991672 cites W3015896992 @default.
• W3048991672 cites W3033128844 @default.
• W3048991672 cites W4237661255 @default.
• W3048991672 cites W4240492649 @default.
• W3048991672 doi "https://doi.org/10.1111/jdv.16866" @default.
• W3048991672 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32790003" @default.
• W3048991672 hasPublicationYear "2020" @default.
• W3048991672 type Work @default.
• W3048991672 sameAs 3048991672 @default.
• W3048991672 citedByCount "40" @default.
• W3048991672 countsByYear W30489916722020 @default.
• W3048991672 countsByYear W30489916722021 @default.
• W3048991672 countsByYear W30489916722022 @default.
• W3048991672 countsByYear W30489916722023 @default.
• W3048991672 crossrefType "journal-article" @default.
• W3048991672 hasAuthorship W3048991672A5034548796 @default.
• W3048991672 hasAuthorship W3048991672A5077025645 @default.
• W3048991672 hasAuthorship W3048991672A5082315246 @default.
• W3048991672 hasConcept C126322002 @default.
• W3048991672 hasConcept C142724271 @default.
• W3048991672 hasConcept C203014093 @default.
• W3048991672 hasConcept C2776688490 @default.
• W3048991672 hasConcept C2777975735 @default.
• W3048991672 hasConcept C2779134260 @default.
• W3048991672 hasConcept C2779806340 @default.
• W3048991672 hasConcept C2780564577 @default.

• next